Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Revvity Inc (RVTY) vs Western Alliance Bancorporation (WAL) Price & Performance

Revvity IncTrade
Western Alliance BancorporationTrade

Price performance (Past 24H)

Key statistics

Revvity Inc vs Western Alliance Bancorporation — how do they compare? Revvity Inc trades at $115.76 (market cap $12.91B), while Western Alliance Bancorporation trades at $81.46 (market cap $8.89B). The key difference: Revvity Inc is the larger of the two by market cap, and Western Alliance Bancorporation pays the higher dividend (2.06%). Which is the better fit depends on your goals.

RVTYWAL
Market Cap
$12.91B$8.89B
Sector
TechnologyFinancials
52-Week High
$117.75$96.08
52-Week Low
$82.26$66.70
Enterprise Value
$15.23B
Dividend Yield
0.24%2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Revvity Inc

RVTY trades at $114.66, up 0.37% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a 54.98% gross margin and $241.20M net income for 2025, supported by positive news including product launches and raised 2026 guidance. Analyst consensus is a buy with a $120.50 price target, indicating potential upside from current levels.

Outlook remains positive due to consistent earnings outperformance and innovation in diagnostics, but risks include high P/E valuation and competitive pressures. Investors may find opportunity in sustained margin strength and AI integration, though macroeconomic sensitivity warrants caution.

Western Alliance Bancorporation

Western Alliance Bancorporation (WAL) trades at $81.39, up 0.06% on the day, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 9.08, net income margin of 25.43%, and consistent earnings beats in recent quarters. Recent developments include the launch of WA VenueX, a digital asset liquidity platform, and recognition as Arizona's top bank by Forbes in 2026.

Outlook remains positive with a consensus price target of $93.86, implying 15% upside, supported by 79% analyst buy ratings. Risks include negative operating cash flow and institutional selling, but revenue growth and profitability trends provide a solid foundation for investor confidence.

Returns comparison

Trailing returns across standard periods

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY

About Western Alliance Bancorporation

Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.

Read more on WAL